ANVS icon

Annovis Bio (ANVS)

NYSE

$2.08

$0.075 (

+3.74%

)

1D
5D
1M
6M
1Y
5Y
Market open

ANVS: $2.08 / ₿ 0 BTC / 2701 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$2.01
$1.54 - $5.50
$72.07M
0.09
$1.98
$620,309.28
34.65M
$2.08 - $2.09
$1.92 - $2.09
No

What is Annovis Bio (ANVS)?

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

The Annovis Bio (ANVS) stock price has been rising

The Annovis Bio, Inc. (ANVS) stock price today is $2.08, reflecting a +3.74% move since the market opened. The company’s market capitalization stands at $72.07M, with a daily trading volume of $620.31K shares. For investors tracking price trends, Annovis Bio, Inc. stock has ranged between $1.92 and $2.09 today. The previous closing price was $2.01.

Get started with Annovis Bio (ANVS)

Ready to get started? Follow the steps below, or read our guide on how to buy Annovis Bio stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy ANVS

Search for ANVS in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy ANVS.

ANVS FAQs

ANVS is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

ANVS is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Annovis Bio, Inc. (ANVS) has traded between a low of $1.54 and a high of $5.50.

ANVS is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Annovis Bio? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
ANVS icon
ANVS

Only available to USA clients through the Kraken app
or Kraken Pro.

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

LICYQ icon

LICYQ

VSTTF icon
ONCO icon

ONCO

Top losers

Compare the worst-performing stocks of 
the day

YOTAR icon

YOTAR

FAASF icon

FAASF

TTOO icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.